经动脉化疗栓塞术单用及联合靶向药物治疗中期肝癌的肝功能变化及预后比较OACSTPCD
Liver function changes and prognosis of intermediate hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization(TACE)versus TACE plus targeted medicine
背景 经动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)和酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKI)是原发性肝细胞癌(hepatocellular carcinoma,HCC)治疗的常用手段,然而关于TACE与TACE-TKI对中期HCC术后肝功能的影响及预后差异的临床研究仍缺乏.目的 比较TACE与TACE-TKI(索拉非尼或仑伐替尼)治疗中期HC…查看全部>>
Background Transcatheter arterial chemoembolization(TACE)and tyrosine kinase inhibitors(TKI)are usually used in treatment of hepatocellular carcinoma(HCC).However,there is a lack of clinical studies examining the influence of TACE and TACE-TKI on postoperative liver function and prognosis in intermediate HCC.Objective To compare the short-term changes in liver function,complications,and survival outcomes(progression-free survival,PFS)associated with TACE and…查看全部>>
王沫萱;程家敏;千年松
解放军医学院,北京 100853||解放军总医院第八医学中心呼吸与危重症医学部胸部肿瘤科,北京 100091解放军总医院第五医学中心肝病医学部肝病科,北京 100039解放军总医院第八医学中心呼吸与危重症医学部胸部肿瘤科,北京 100091
临床医学
中期肝细胞癌经动脉化疗栓塞术索拉非尼仑伐替尼肝功能术后并发症
intermediate hepatocellular carcinomatranscatheter arterial chemoembolizationsorafeniblenvatinibliver functionpostoperative complications
《解放军医学院学报》 2024 (3)
230-238,9
科技青年培育计划(2019NPY112)海南省重点研发项目(ZDYF2023SHFZ117)
评论